lV-120 Circulation December 13. 2005 Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med. 91. Bhalla A, Sankaralingam S, Tilling K, Swaminathan R, Wolfe C, Rudd A. 005:45:377-384 Effect of ac come after acute stroke 71. Katzan IL, Furlan A, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Cerebronasc Dis. 2002: 13: 95-101 Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen acti 2. Bruno A. Biller J. Adams HP Jr, Clarke WR, Woolson RF. Williams Ls te ischemic stroke: the Cleveland area experience. JAMA hrcoboleis lansen MD. Acute blood glucose level and outcome from ischemic stroke. l151-1158 Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators 72. Bravata DM. Kim N. Concato J Krumholz HM. Brass LM. Thr oloy.199952:280-284 for acute stroke in routine clinical practice. Arch Intem Med. 93. Celik Y, Utku U, Asil T, Balci K. Factors affecting haemorrhagic transfor- on in middle cerebral artery infarctions. J Clin Neurosci. 2004; I1 73. Lopez-Yunez AM, Bruno A, Williams LS, Yilmaz E, Zurru Protocol violations in community-based rTPA stroke tre 94. williams LS, Rotich J, QiR, Fineberg N, Espay A, Bruno A, Fineberg SE ciated with symptomatic intracerebral hemorrhage. Stroke. 2001: on mortality and costs in 74. Asimos Aw, Norton H, Price MF, Cheek WM. Therapeutic yield and cute ischemic stroke. Neurology. 2002: 59: 67- utcomes of a community teaching hospital code stroke protocol. Acad 95. Scout JF. Robinson GM, French JM, O Connell JE, Alberti KG, Gray Cs. Emerg Med.2004:11:36l-370. Glucose potassium insulin infusions in the treatment of acute stroke patients 75. Katzan IL, Hammer MD, Furlan A, Hixson ED, Nadzam DM. Quality vith mild to moderate hyperglycemia: the Glucose Insulin in Stroke Tria aprovement and tissue-type plasminogen activator for acute ischemic GIsT. Stroke.199930:793-799 stroke: a Cleveland update. Stroke. 2003: 34: 799-800 96. Gray CS, Hildreth AJ, Alberti GK, OConnell JE. Poststroke hyper- 6. Lattimore SU, Chalela J, Davis L, DeGraba T, Ezzeddine M, Haymore J emia: natural history and immediate management. Stroke. 2004; 35 Nyquist P, Baird AE, Hallenbeck J, Warach S Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience. Stroke. Schetz M, vlasselaers D, Ferdinande p, lauwers P. Bouillon 2003:34:e55-e57 sulin therapy in the critically ill patients. N Engl J Med. 2001: 345: 77. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, 359-136 Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial 98. Adams H, Brott T, Crowell R, Furlan A, Gomez C, Grotta J, Helgason C, urokinase for acute ischemic stroke: the PROACT II study: a ran- Marler J, woolson R, Zivin J, Feinberg w, Mayberg M. Guidelines for th omized controlled trial. Prolyse in Acute Cerebral Thromboembolism. with acute ischemic stroke JAMA.19992822003-2011. ng group of the Stroke Council, 78. Combined intravenous and intra-arterial recanalization for acute ischemic American Heart Association. Stroke. 1994: 25: 1901-1914 roke: the Interventional Management of Stroke Study. Stroke. 2004 3 99. Hajat C. Hajat S. Sharma P. Effects of poststroke pyrexia on stroke utcome: a meta-analysis of studies in patients. Stroke. 200031: 410-414. 9. Suarez JI. Sunshine JL, Tarr R, Zaidat O. Selman WR. Kemich C, Land 100. Azzimondi G, Bassein L, Nonino F. Fiorani L, Vignatelli L. Re G. DM. Predictors of clinical improvement, angiographic recanalization, and acute stroke worsens prognosis: a prospective ntracranial hemorrhage after intra-arterial thrombolysis for acute ischemic study. Stroke.1995:262040-2043. roke. Stroke.199930:2094-2100. 101. Reith J, Jorgensen HS, Pedersen PM. Nakayama H, Raaschou HO, Jeppesen 80. Gonner F. Remonda L, Mattle H, Sturzenegger M, Ozdoba C, Lovblad KO LL, Olsen TS. Body temperature in acute stroke: relation to stroke severity. Baumgartner Bassetti C, Schroth G. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke. 1998. 29:1894-1900 2. Boyson G, Christenson H. Stroke severity determines body temperature in 81. Suarez Jl. Zaidat OO. Sunshine JL, Tarr R. Selman WR Landis DM. cute stroke. Stroke. 2001: 32: 413-417 ndovascular administration after intravenous infusion of thrombolytic rents for the of patients with acute ischemic strokes. Neuro- SM, Koroshetz wJ, Rordorf G, Warach S Cooling for Acute Ischemic ngen.2002:50:251-259; discussion259-260. rain Damage(COOL AID): a feasibility trial of endovascular cooling. 82. Ernst R, Pancioli A. Tomsick T, Kissela B, Woo D. Kanter D, Jauch E urology.200463:312-31 Carmozzella J, Spilker J, Broderick J. Combined intravenous and intra-arte- 104. Georgiadis D. Schwarz S. Aschoff A, Schwab ectomy and rial recombinant tissue plasminogen activator in acute ischemic stroke. moderate hypothermia in patients with severe ischemic stroke Stroke. 20 stroke.2000:31:252-2557 :1584-1 ourekas EC. Slivka AP. Shah R. Sunshine J. Suarez JI Intra-arterial 105. Georgiadis D, Schwarz S Kollmar R, Schwab S. Endovascular cooling for noderate hypothermia in patients with acute stroke: first results of a novel nrombolytic therapy within 3 hours of the onset of stroke. Neurosurgery. 2004:5439-44; discussion44-46 approach. Stroke. 2001: 32: 2550-2553. 106. Wang H. olivero W. Lanzino g. Elkins w, Rose J Honings D. Rodde M, intra-arterialintravenous thrombolysis for acute ischemic stroke. ANR Burnham J, Wang D Rapid and selective cerebral hypothermia achieved sing a cooling helmet. J Neurosurg. 2004: 100: 272-277 Am J Neuroradiol. 2001: 22- 352-358 85. Ueda T, Sakaki S, Kumon Y, Ohta S. Multivariable analysis of predictive 107. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W factors related to outcome at 6 months after intra-arterial thrombolysis for cerebral artery infarction Stroke. 1998: 29: 2461-2466 uckwiler GR Kidwell CS 108. Schwab S, Georgiadis D. Bermouschot J. Schellinger PD, Graffanino C P. Villablanca JP Saver J, Starkman S, Martin N, Vinuela F. Intra-arterial thrombolysis for Mayer SA. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke. 2001: 32: 2033-20 atients with long-term follow-up. AJNR Am J Neuroradiol. 1999, 20: 1291-1299. 109. Kammersgaard LP, Rasmussen BH, Jorgensen HS, Reith J, Weber U, Olsen TS Feasibility and safety of inducing modest hypothermia in awake patients 87. Alvarez-Sabin J Molina CA. Montaner J. Arenillas JF. Huertas R. Ribo M with acute stroke through surface cooling: a case-control study: the odina A, Quintana M. Effects of admission hyperglycemia on stroke openhagen Stroke Study. Stroke. 2000: 31: 2251-2556 110. Knoll T, Wimmer ML, Gumpinger F Haberl RL. The low normothermia 2003:34:1235-1241 concept-maintaining a core body temperature between 36 and 37 degr aird TA, Parsons MW, Phanh T, Butcher Ks, Desmond PM.? C in acute stroke unit patients. J Neurosurg Anesthesiol 2002: 14:304-308 olman PG, Chambers BR. Davis SM. Persistent poststroke hyp Ill. Krieger Dw, De Georgia MA, Abou-Chebl A, Andrefsky JC, Sila CA, independently associated with infarct expansion and wor Mayberg mr. furla ischemic brain utcome. Stroke.2003:342208-2214. amage(COOL AID): an open pilot study of induced hypothermia in acut Parsons MW, Barber PA, Desmond PM. Baird T G, Byrnes G. hemic stroke Stroke. 2001: 32: 1847-1854. ress BM, Davis SM Acute hyperglycemia 112. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypo- utcome: a magnetic resonance imaging and study. Ann ermia to improve the neurologic outcome after cardiac arrest. N Engi JMed.2002:346:549-556 0. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyper- 113. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, glycemia and prognosis of stroke in nondiabetic and diabetic patients Smith K Treatment of comatose survi cardiac arres systematic overview. Stroke. 2001: 32: 2426-2432. vith induced hypothermia. N Engl J Med. 2002; 346 557-563.Recombinant Tissue Plasminogen Activator Stroke Study. Ann Emerg Med. 2005;45:377–384. 71. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA. 2000;283: 1151–1158. 72. Bravata DM, Kim N, Concato J, Krumholz HM, Brass LM. Thrombolysis for acute stroke in routine clinical practice. Arch Intern Med. 2002;162: 1994 –2001. 73. Lopez-Yunez AM, Bruno A, Williams LS, Yilmaz E, Zurru C, Biller J. Protocol violations in community-based rTPA stroke treatment are asso￾ciated with symptomatic intracerebral hemorrhage. Stroke. 2001;32:12–16. 74. Asimos AW, Norton HJ, Price MF, Cheek WM. Therapeutic yield and outcomes of a community teaching hospital code stroke protocol. Acad Emerg Med. 2004;11:361–370. 75. Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke. 2003;34:799 – 800. 76. Lattimore SU, Chalela J, Davis L, DeGraba T, Ezzeddine M, Haymore J, Nyquist P, Baird AE, Hallenbeck J, Warach S. Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience. Stroke. 2003;34:e55–e57. 77. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a ran￾domized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282:2003–2011. 78. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004;35: 904 –911. 79. Suarez JI, Sunshine JL, Tarr R, Zaidat O, Selman WR, Kernich C, Landis DM. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2094 –2100. 80. Gonner F, Remonda L, Mattle H, Sturzenegger M, Ozdoba C, Lovblad KO, Baumgartner R, Bassetti C, Schroth G. Local intra-arterial thrombolysis in acute ischemic stroke. Stroke. 1998;29:1894 –1900. 81. Suarez JI, Zaidat OO, Sunshine JL, Tarr R, Selman WR, Landis DM. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neuro￾surgery. 2002;50:251–259; discussion 259 –260. 82. Ernst R, Pancioli A, Tomsick T, Kissela B, Woo D, Kanter D, Jauch E, Carrozzella J, Spilker J, Broderick J. Combined intravenous and intra-arte￾rial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke. 2000;31:2552–2557. 83. Bourekas EC, Slivka AP, Shah R, Sunshine J, Suarez JI. Intra-arterial thrombolytic therapy within 3 hours of the onset of stroke. Neurosurgery. 2004;54:39 – 44; discussion 44 – 46. 84. Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J. Combined intra-arterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol. 2001;22:352–358. 85. Ueda T, Sakaki S, Kumon Y, Ohta S. Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30:2360 –2365. 86. Jahan R, Duckwiler GR, Kidwell CS, Sayre JW, Gobin YP, Villablanca JP, Saver J, Starkman S, Martin N, Vinuela F. Intra-arterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol. 1999;20:1291–1299. 87. Alvarez-Sabin J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, Codina A, Quintana M. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator–treated patients. Stroke. 2003;34:1235–1241. 88. Baird TA, Parsons MW, Phanh T, Butcher KS, Desmond PM, Tress BM, Colman PG, Chambers BR, Davis SM. Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke. 2003;34:2208 –2214. 89. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, Tress BM, Davis SM. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20 –28. 90. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyper￾glycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426 –2432. 91. Bhalla A, Sankaralingam S, Tilling K, Swaminathan R, Wolfe C, Rudd A. Effect of acute glycaemic index on clinical outcome after acute stroke. Cerebrovasc Dis. 2002;13:95–101. 92. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, Hansen MD. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999;52:280 –284. 93. Celik Y, Utku U, Asil T, Balci K. Factors affecting haemorrhagic transfor￾mation in middle cerebral artery infarctions. J Clin Neurosci. 2004;11: 656 – 658. 94. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology. 2002;59:67–71. 95. Scott JF, Robinson GM, French JM, O’Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke. 1999;30:793–799. 96. Gray CS, Hildreth AJ, Alberti GK, O’Connell JE. Poststroke hyper￾glycemia: natural history and immediate management. Stroke. 2004;35: 122–126. 97. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345: 1359 –1367. 98. Adams HJ, Brott T, Crowell R, Furlan A, Gomez C, Grotta J, Helgason C, Marler J, Woolson R, Zivin J, Feinberg W, Mayberg M. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke. 1994;25:1901–1914. 99. Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke. 2000;31:410 – 414. 100. Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G, D’Alessandro R. Fever in acute stroke worsens prognosis: a prospective study. Stroke. 1995;26:2040 –2043. 101. Reith J, Jorgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347:422– 425. 102. Boyson G, Christenson H. Stroke severity determines body temperature in acute stroke. Stroke. 2001;32:413– 417. 103. De Georgia MA, Krieger DW, Abou-Chebl A, Devlin TG, Jauss M, Davis SM, Koroshetz WJ, Rordorf G, Warach S. Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling. Neurology. 2004;63:312–317. 104. Georgiadis D, Schwarz S, Aschoff A, Schwab S. Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke. Stroke. 2002; 33:1584 –1588. 105. Georgiadis D, Schwarz S, Kollmar R, Schwab S. Endovascular cooling for moderate hypothermia in patients with acute stroke: first results of a novel approach. Stroke. 2001;32:2550 –2553. 106. Wang H, Olivero W, Lanzino G, Elkins W, Rose J, Honings D, Rodde M, Burnham J, Wang D. Rapid and selective cerebral hypothermia achieved using a cooling helmet. J Neurosurg. 2004;100:272–277. 107. Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke. 1998;29:2461–2466. 108. Schwab S, Georgiadis D, Berrouschot J, Schellinger PD, Graffagnino C, Mayer SA. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke. 2001;32:2033–2035. 109. Kammersgaard LP, Rasmussen BH, Jorgensen HS, Reith J, Weber U, Olsen TS. Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: a case-control study: the Copenhagen Stroke Study. Stroke. 2000;31:2251–2556. 110. Knoll T, Wimmer ML, Gumpinger F, Haberl RL. The low normothermia concept—maintaining a core body temperature between 36 and 37 degrees C in acute stroke unit patients. J Neurosurg Anesthesiol. 2002;14:304 –308. 111. Krieger DW, De Georgia MA, Abou-Chebl A, Andrefsky JC, Sila CA, Katzan IL, Mayberg MR, Furlan AJ. Cooling for acute ischemic brain damage (COOL AID): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke. 2001;32:1847–1854. 112. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypo￾thermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346:549 –556. 113. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557–563. IV-120 Circulation December 13, 2005